| human | Q5 |
| P6178 | Dimensions author ID | 010112301517.33 |
| P496 | ORCID iD | 0000-0002-1153-0192 |
| P108 | employer | Imperial College London | Q189022 |
| P734 | family name | Pickering | Q11213243 |
| Pickering | Q11213243 | ||
| Pickering | Q11213243 | ||
| P735 | given name | Matthew | Q4927231 |
| Matthew | Q4927231 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q36050943 | A hybrid CFHR3-1 gene causes familial C3 glomerulopathy. |
| Q37212087 | A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry |
| Q36057084 | Acute presentation and persistent glomerulonephritis following streptococcal infection in a patient with heterozygous complement factor H-related protein 5 deficiency |
| Q36495141 | Annexin A2 Enhances Complement Activation by Inhibiting Factor H |
| Q61651856 | Are anti-C1q antibodies different from other SLE autoantibodies? |
| Q33401386 | Atypical hemolytic uremic syndrome and genetic aberrations in the complement factor H-related 5 gene |
| Q33392073 | Atypical hemolytic uremic syndrome: telling the difference between H and Y. |
| Q61651871 | Bilateral gluteal abscesses as a unique manifestation of Fusobacterium septicaemia |
| Q35097512 | Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injury |
| Q37644173 | C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo. |
| Q36891110 | C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation |
| Q37770399 | C3 glomerulopathy: a new classification |
| Q37426966 | C3 glomerulopathy: clinicopathologic features and predictors of outcome |
| Q37348685 | C3 glomerulopathy: consensus report |
| Q38209618 | C3 glomerulopathy: the genetic and clinical findings in dense deposit disease and C3 glomerulonephritis. |
| Q61651859 | Complement C1q and C8 deficiency in an individual with recurrent bacterial meningitis and adult-onset systemic lupus erythematosus-like illness |
| Q61651866 | Complement Factor H Limits Immune Complex Deposition and Prevents Inflammation and Scarring in Glomeruli of Mice with Chronic Serum Sickness |
| Q47603343 | Complement Regulatory Protein Factor H Is a Soluble Prion Receptor That Potentiates Peripheral Prion Pathogenesis |
| Q37310565 | Complement alternative pathway genetic variation and Dengue infection in the Thai population |
| Q34762966 | Complement component C3 plays a critical role in protecting the aging retina in a murine model of age-related macular degeneration |
| Q33301870 | Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction |
| Q94533029 | Complement factor H-deficient mice develop spontaneous hepatic tumors |
| Q37501005 | Complement in human diseases: Lessons from complement deficiencies |
| Q28511540 | Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injury |
| Q37362130 | Decay-accelerating factor suppresses complement C3 activation and retards atherosclerosis in low-density lipoprotein receptor-deficient mice |
| Q37286653 | Dense deposit disease and C3 glomerulopathy |
| Q35124165 | Dense deposit disease. |
| Q27675010 | Design and Evaluation of Meningococcal Vaccines through Structure-Based Modification of Host and Pathogen Molecules |
| Q36793448 | Detection of complement activation using monoclonal antibodies against C3d. |
| Q36034520 | Detection of glomerular complement C3 fragments by magnetic resonance imaging in murine lupus nephritis |
| Q27676814 | Dimerization of complement factor H-related proteins modulates complement activation in vivo |
| Q36714001 | Essential role of surface-bound complement factor H in controlling immune complex-induced arthritis |
| Q41443111 | Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase |
| Q24651118 | Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice |
| Q61651869 | False-positive results obtained using the Mantoux test in Behçet's syndrome: Comment on the article by García-Porrúa et al |
| Q61651844 | Hyperfunctional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in mice |
| Q24615589 | Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis |
| Q37397572 | Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation |
| Q54325393 | Lateral medullary syndrome with anti-neuronal antibodies (anti-Ta/Ma2) in primary Sjogren's syndrome. |
| Q36509318 | Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency |
| Q61651862 | Mesangial immune complex glomerulonephritis due to complement factor D deficiency |
| Q36860946 | New approaches to the treatment of dense deposit disease |
| Q38328071 | Nonfunctional variant 3 factor H binding proteins as meningococcal vaccine candidates |
| Q37211139 | P2X7 deficiency attenuates renal injury in experimental glomerulonephritis |
| Q61651853 | Painful myositis in the anti-synthetase syndrome with anti-PL12 antibodies |
| Q34602983 | Phagocytosis is the main CR3-mediated function affected by the lupus-associated variant of CD11b in human myeloid cells |
| Q34537391 | Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice |
| Q61651865 | Proteomic Profiling of Urinary Protein Excretion in the Factor H-Deficient Mouse |
| Q38088187 | Recent insights into C3 glomerulopathy |
| Q34467879 | Recurrence of complement factor H-related protein 5 nephropathy in a renal transplant |
| Q35532337 | Regulating complement in the kidney: insights from CFHR5 nephropathy |
| Q61651852 | Relationship between complotype and reported severity of systemic allergic reactions to peanut |
| Q57089437 | SLE with C1q deficiency treated with fresh frozen plasma: a 10-year experience |
| Q33382197 | Shiga toxin-2 results in renal tubular injury but not thrombotic microangiopathy in heterozygous factor H-deficient mice. |
| Q33375335 | Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains |
| Q34082803 | Systemic lupus erythematosus, complement deficiency, and apoptosis |
| Q28300378 | The development of atypical hemolytic uremic syndrome depends on complement C5 |
| Q33378236 | Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals. |
| Q34005720 | Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice |
| Q57089553 | Ultraviolet-Radiation-Induced Keratinocyte Apoptosis in C1q-Deficient Mice |
| Q57089510 | Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H |
Search more.